Presence of antibodies against cyclic citrullinated peptides in patients with 'rhupus': a cross-sectional study
Open Access
- 1 January 2006
- journal article
- research article
- Published by Springer Science and Business Media LLC in Arthritis Research & Therapy
- Vol. 8 (5), R144
- https://doi.org/10.1186/ar2036
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Lupus arthropathy: a case series of patients with rhupusClinical Rheumatology, 2006
- Presence of rheumatoid factor and antibodies to citrullinated peptides in systemic lupus erythematosusAnnals Of The Rheumatic Diseases, 2005
- Rheumatoid factor and anticitrullinated protein antibodies in rheumatoid arthritis: diagnostic value, associations with radiological progression rate, and extra-articular manifestationsAnnals Of The Rheumatic Diseases, 2004
- Evaluation of anti-citrullinated filaggrin antibodies as hallmarks for the diagnosis of rheumatic diseasesAnnals Of The Rheumatic Diseases, 2004
- Expression and activity of citrullinating peptidylarginine deiminase enzymes in monocytes and macrophagesAnnals Of The Rheumatic Diseases, 2004
- Clinical and immunogenetic characterization of Mexican patients with ‘Rhupus’Lupus, 2002
- Use of anti-citrullinated peptide and anti-RA33 antibodies in distinguishing erosive arthritis in patients with systemic lupus erythematosus and rheumatoid arthritisAnnals Of The Rheumatic Diseases, 2001
- Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies.JCI Insight, 1998
- The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritisArthritis & Rheumatism, 1988
- The 1982 revised criteria for the classification of systemic lupus erythematosusArthritis & Rheumatism, 1982